Notably, SPP1 was identified as a key target gene, and thorough experimental validation underscored its role in fostering resistance to anoikis in HCC by modulating the PI3K/AKT/mTOR signaling pathway. The gene discussed is MTOR; the disease is hepatocellular carcinoma.